ReviewFrontiers in pharmacology2022

Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer.

Mengjiao Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.